{"protocolSection":{"identificationModule":{"nctId":"NCT02960126","orgStudyIdInfo":{"id":"CESAC-AF"},"organization":{"fullName":"Chuncheon Sacred Heart Hospital","class":"OTHER"},"briefTitle":"Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk","officialTitle":"Comparison of Efficacy and Safety Between Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk","acronym":"CESAC-AF"},"statusModule":{"statusVerifiedDate":"2016-11","overallStatus":"UNKNOWN","lastKnownStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-11"},"primaryCompletionDateStruct":{"date":"2020-10","type":"ESTIMATED"},"completionDateStruct":{"date":"2021-10","type":"ESTIMATED"},"studyFirstSubmitDate":"2016-11-02","studyFirstSubmitQcDate":"2016-11-08","studyFirstPostDateStruct":{"date":"2016-11-09","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-11-08","lastUpdatePostDateStruct":{"date":"2016-11-09","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Sang Min Park","investigatorTitle":"Professor","investigatorAffiliation":"Chuncheon Sacred Heart Hospital"},"leadSponsor":{"name":"Chuncheon Sacred Heart Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"This study was designed in order to evaluate and compare the efficacy and safety between aspirin and clopidogrel in the patient with low stroke risk Atrial Fibrillation (AF).","detailedDescription":"Efficacy outcome will be evaluated the major cerebro-cardiovascular event including stroke, cardiovascular death, and myocardial infarction during 1 year-medication period. In addition, safety outcome will be evaluated the gastrointestinal responses including peptic ulcer and upper gastrointestinal bleeding events to both study drugs by repeated gastroenteroscopic examinations before and after medication by GI specialist."},"conditionsModule":{"conditions":["Atrial Fibrillation"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":1500,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention: Clopidogrel","type":"ACTIVE_COMPARATOR","description":"Case management with clopidogrel 75mg once daily is provided for stroke prevention in AF patient.","interventionNames":["Drug: Clopidogrel"]},{"label":"Control: Aspirin","type":"EXPERIMENTAL","description":"Usual care with aspirin 100mg once daily is provided for stroke prevention in AF patient.","interventionNames":["Drug: Aspirin"]}],"interventions":[{"type":"DRUG","name":"Aspirin","armGroupLabels":["Control: Aspirin"]},{"type":"DRUG","name":"Clopidogrel","armGroupLabels":["Intervention: Clopidogrel"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Major Cerebrovascular and cardiac events including stroke, CV death, MI","description":"Number of each event","timeFrame":"1 year after randomization"},{"measure":"Major gastrointestinal event including peptic ulcer disease and bleeding","description":"Number of each event","timeFrame":"1 year after randomization"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Man or Women \\> 20 years old\n2. newly detected AF (CHA2DS2VASc index score: 1)\n3. Patient who needs antiplatelet therapy using aspirin clopidogrel for stroke prevention\n4. volunteer only\n5. childbearing aged women who takes proper oral contraceptive\n\nExclusion Criteria:\n\n1. No specific contraindication or any history of hypersensitivity of Clopidogrel or aspirin\n2. Patient with active GI bleeding or bleeding tendency or major bleeding history\n3. less than 1 year of residual expected life\n4. Pregnant or breast-feeding women\n5. Other causes, determined by charged physician\n6. Patient with definite GERD who needs special treatment\n7. Patient who needs to take NSAID (Non-Steroidal Anti-Inflammatory Drug) for more than 2 weeks","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"]},"referencesModule":{"references":[{"pmid":"28642210","type":"DERIVED","citation":"Park SM, Jeong H, Jung MH, Hong KS, Hong MK, Bang CS, Kim CY. Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial. Contemp Clin Trials. 2017 Sep;60:51-55. doi: 10.1016/j.cct.2017.06.011. Epub 2017 Jun 19."}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001241","term":"Aspirin"},{"id":"D000077144","term":"Clopidogrel"}],"ancestors":[{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000058921","term":"Purinergic P2Y Receptor Antagonists"},{"id":"D000058919","term":"Purinergic P2 Receptor Antagonists"},{"id":"D000058914","term":"Purinergic Antagonists"},{"id":"D000058905","term":"Purinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","asFound":"Knee","relevance":"HIGH"},{"id":"M1669","name":"Clopidogrel","asFound":"Results","relevance":"HIGH"},{"id":"M3907","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M3908","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M20476","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M20294","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M18899","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M28866","name":"Antipyretics","relevance":"LOW"},{"id":"M28984","name":"Purinergic P2Y Receptor Antagonists","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}